The First Diagnosed Case of Steroid-induced Kaposi's Sarcoma in Mongolia

Authors

  • Khandsuren Byamba Department of Dermatology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Ariunaa Munkhbayar Department of Clinical Pathology, National Dermatology Center of Mongolia, Ulaanbaatar, Mongolia
  • Oyuntsatsral Batsaikhan Department of Dermatology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Undram Sainzaya Department of Research and Training, National Dermatology Center of Mongolia, Ulaanbaatar, Mongolia

DOI:

https://doi.org/10.24079/cajms.2016.01.016

Keywords:

Sarcoma, Adrenal Cortex Hormones, Herpesvirus 8, Human

Abstract

Objectives: Kaposi's sarcoma (KS) is a vascular neoplasm with four main types. We report the first diagnosed case of steroid-induced KS in a non-HIV patient in Mongolia. Methods: A 57-year-old man presented hemorrhagic spots on his body after seven months of corticosteroid therapy due to the glomerulonephritis. Upon examination, the morphology, histopathology and immunohistochemistry indicated human herpes virus-8 (HHV-8) positive KS. Results: After the dose reduction of corticosteroids the lesions remarkably diminished in size and almost resolved as observed at the six-month follow-up. Conclusion: Medical professionals should be aware of the appearance of KS in patients receiving immunosuppressive therapies.

Downloads

Download data is not yet available.
Abstract
39
PDF
76

Downloads

Published

2016-06-25

How to Cite

Byamba, K., Munkhbayar, A., Batsaikhan, O., & Sainzaya, U. (2016). The First Diagnosed Case of Steroid-induced Kaposi’s Sarcoma in Mongolia. Central Asian Journal of Medical Sciences, 2(1), 101–104. https://doi.org/10.24079/cajms.2016.01.016

Issue

Vol. 2 No. 1 (2016)

Section

Case Reports

License

Copyright (c) 2016 Mongolian National University of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.